Advanced wound care, made personal

A lightweight device, that fits seamlessly into standard of care A lightweight device, that fits seamlessly into standard of care
Swiss Medical Technology

A lightweight device, that fits seamlessly into standard of care

Get to know our product

The benefits of COMS®-Technology*

Treatment of chronic wounds represents a challenge for both the patient and modern healthcare systems

How it works
Accelerated Wound Closure

Accelerated Wound Closure

To produce a durable closure for hard-to-heal wounds.

Intuitive

Intuitive

Treatment is non-invasive and easy to learn.

Decreased Costs

Decreased Costs

Healing of chronic wounds significantly decreases the financial burden of modern health care.

Platform Technology

Platform Technology

The underlying mechanism of action can be applied to different pathological conditions.


*The COMS® One therapy system is not cleared in the US.

Who are we?

Who are we?

We are a young company founded and based in Zurich, Switzerland since 2016. The Piomic family consists of biologists, engineers, entrepreneurs, designers, seniors and a broad group of supporters. Staffed with experts from different backgrounds and a common goal: By developing a therapy which is safe and effective, we want to set a better future for patients in need.

More about us

Do you want to contribute to our vision?

Do you want to contribute to our vision?

In order to maximize our global impact, we are looking for investors who share our vision and wish to shape the future of wound care with us.

Information for investors

Latest news

Piomic Medical Announces First Patients Enrolled in MAVERICKS Study Sites

03 Sep 2023

Trial seeks to assure Piomic’s COMS® treatment is safe and effective in therapy-refractory diabetic foot ulcers

Read more
Piomic Medical Announces First Patients Enrolled in MAVERICKS Study Sites
Piomic receives Medicare Category B Designation for MAVERICKS clinical trial

31 Aug 2023

CMS has approved the COMS One device for Category B designation and for Medicare coverage purposes during Piomic's IDE study

Read more
Piomic receives Medicare Category B Designation for MAVERICKS clinical trial
Piomic receives certification under MDR, the new European Medical Device Regulation

27 Apr 2023

Piomic Medical has received certificates according to MDR for its Class IIa and Class Is medical devices of the COMS® One Therapy System.

Read more
Piomic receives certification under MDR, the new European Medical Device Regulation
Bernard Laurel appointed as the President of Piomic Medical Inc.

10 Feb 2023

M&A experienced advanced wound care leader appointed as President of US Subsidiary Piomic Medical Inc.

Read more
Bernard Laurel appointed as the President of Piomic Medical Inc.
Don't miss our updates!
You must complete your email.
You must accept our Privacy Policy

Our Partners

Do you want to cooperate with us?

We are constantly trying to expand our interdisciplinary know-how and increase the impact of our novel technology on the lives of patients. Therefore we are looking to conncet to the brightest minds in their field of expertise and share our knowledge to create easy-to-use products and innovative wound care solutions.